The patient was implanted with a left ventricular assist device (lvad) on (b)(6) 2016.It was reported that the patient presented to the clinic on (b)(6) 2018, and was admitted into the hospital due to complaints of nausea, increasing palpitations, shortness of breath, and chest pressure.On (b)(6) 2018, it was reported that elevated pump powers and flow estimation had been occurring.The patient had undergone outflow graft stenting for outflow graft narrowing on (b)(6) 2017.Since (b)(6) 2018 the patient¿s lactate dehydrogenase level had been elevated in the 12-1400 u/l range.International normalized ratio had been therapeutic.The patient was on aspirin and plavix.On (b)(6) 2018, the lvad clinician reported that the pump was exchanged with another manufacturer¿s pump on (b)(6) 2018, due to wide open aortic insufficiency and device thrombosis.No additional information was provided.
|